Herpes zoster vaccine may benefit RA patients

									sph |
																			February 12, 2015
					

Marc VacquierResearch by HSRP&A PhD student, Marc Vacquier, suggests that the herpes zoster vaccine may benefit patients with rheumatoid arthritis (RA). Without the vaccination, the risk for herpes zoster (commonly known as shingles) in patients with RA is approximately double that of the general population. Vacquier’s findings were published in Value-Based Care in Rheumatology after he presented his research at the Society for Medical Decision Making’s 36th Annual North American meeting, Oct. 2014. Read more about Vacquier’s findings.

 

© 2015 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement